EFFECT OF METHIONINE AND NITROUS-OXIDE ON HOMOCYSTEINE EXPORT AND REMETHYLATION IN FIBROBLASTS FROM CYSTATHIONINE SYNTHASE-DEFICIENT, CB1G, AND CB1E PATIENTS

被引:12
作者
CHRISTENSEN, B
ROSENBLATT, DS
CHU, RC
UELAND, M
机构
[1] UNIV BERGEN,HAUKELAND HOSP,DEPT PHARMACOL & TOXICOL,CLIN PHARMACOL UNIT,N-5021 BERGEN,NORWAY
[2] MCGILL UNIV,CTR HUMAN GENET,MRC,GENET GRP,MONTREAL H3A 1A1,QUEBEC,CANADA
[3] VET ADM MED CTR,ALBANY,NY 12208
关键词
D O I
10.1203/00006450-199401000-00002
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We investigated the nitrous oxide-induced inactivation of methionine synthase and the concurrent homocysteine (Hcy) export in mutant fibroblasts with defects in the homocysteine catabolizing enzyme, cystathionine beta-synthase, or in methionine synthase, which carries out homocysteine remethylation. The fibroblasts were incubated in various concentrations of methionine to create conditions favoring methionine conservation or catabolism. In cystathionine beta-synthase-deficient cells, high medium methionine partly protected the enzyme against inactivation, as previously found in normal fibroblasts. The Hcy export rate at low methionine levels was low (0.2-0.6 nmol/h/10(6) cells), and increased 2-3-fold at high methionine levels. Nitrous oxide enhanced Hcy export rate at low methionine, so that in the presence of nitrous oxide, the Hcy export became less dependent of methionine. In cb1G cells, the enzyme inactivation was moderate and independent of medium methionine. The Hcy export rate was intermediate (0.5-0.8 nmol/h/10(6) cells) at low methionine levels, and increased moderately (<2-fold) at high methionine levels or following nitrous oxide exposure. In cb1E mutants, the enzyme activity was not affected by nitrous oxide, and the Hcy export was high (0.8-1.6 nmol/h/10(6) cells) and independent of methionine and nitrous oxide. These data suggest that Hcy remethylation and cystathionine beta-synthase activity are major determinants of Hcy export at low and high methionine, respectively. The low susceptibility of methionine synthase to nitrous oxide in the presence of high methionine or in cb1G or cb1E mutants is probably related to low catalytic turnover.
引用
收藏
页码:3 / 9
页数:7
相关论文
共 30 条
[1]   DIAGNOSIS OF COBALAMIN DEFICIENCY .1. USEFULNESS OF SERUM METHYLMALONIC ACID AND TOTAL HOMOCYSTEINE CONCENTRATIONS [J].
ALLEN, RH ;
STABLER, SP ;
SAVAGE, DG ;
LINDENBAUM, J .
AMERICAN JOURNAL OF HEMATOLOGY, 1990, 34 (02) :90-98
[2]   REACTIONS OF GASES IN SOLUTION .3. SOME REACTIONS OF NITROUS OXIDE WITH TRANSITION-METAL COMPLEXES [J].
BANKS, RGS ;
HENDERSON, RJ ;
PRATT, JM .
JOURNAL OF THE CHEMICAL SOCIETY A -INORGANIC PHYSICAL THEORETICAL, 1968, (12) :2886-+
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   HIGHER TOTAL PLASMA HOMOCYSTEINE IN VITAMIN-B12 DEFICIENCY THAN IN HETEROZYGOSITY FOR HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY [J].
BRATTSTROM, L ;
ISRAELSSON, B ;
LINDGARDE, F ;
HULTBERG, B .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1988, 37 (02) :175-178
[5]   IMPAIRED HOMOCYSTEINE METABOLISM IN EARLY-ONSET CEREBRAL AND PERIPHERAL OCCLUSIVE ARTERIAL-DISEASE - EFFECTS OF PYRIDOXINE AND FOLIC-ACID TREATMENT [J].
BRATTSTROM, L ;
ISRAELSSON, B ;
NORRVING, B ;
BERGQVIST, D ;
THORNE, J ;
HULTBERG, B ;
HAMFELT, A .
ATHEROSCLEROSIS, 1990, 81 (01) :51-60
[6]  
CHRISTENSEN B, 1992, J PHARMACOL EXP THER, V261, P1096
[7]   HOMOCYSTEINE EXPORT FROM CELLS CULTURED IN THE PRESENCE OF PHYSIOLOGICAL OR SUPERFLUOUS LEVELS OF METHIONINE - METHIONINE LOADING OF NONTRANSFORMED, TRANSFORMED, PROLIFERATING, AND QUIESCENT CELLS IN CULTURE [J].
CHRISTENSEN, B ;
REFSUM, H ;
VINTERMYR, O ;
UELAND, PM .
JOURNAL OF CELLULAR PHYSIOLOGY, 1991, 146 (01) :52-62
[8]  
CHRISTENSEN B, 1993, IN PRESS J PHARM EXP
[9]  
COOPER BA, 1987, ANNU REV NUTR, V7, P291, DOI 10.1146/annurev.nu.07.070187.001451
[10]   MONITORING COBALAMIN INACTIVATION DURING NITROUS-OXIDE ANESTHESIA BY DETERMINATION OF HOMOCYSTEINE AND FOLATE IN PLASMA AND URINE [J].
ERMENS, AAM ;
REFSUM, H ;
RUPREHT, J ;
SPIJKERS, LJM ;
GUTTORMSEN, AB ;
LINDEMANS, J ;
UELAND, PM ;
ABELS, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (04) :385-393